Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-limiting pain management in urethroplasty
NCT03859024Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2019
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib oral solution, gabapentin, bupivacaine and dexamethasone in postoperative pain, sponsored by University of Alabama at Birmingham. Started Mar 2019; status: completed.
02
Drugs
celecoxib oral solutiongabapentinbupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03859024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03859024.